Digital microfluidic assay for protein detection.
Global studies of the human proteome have revealed a plethora of putative protein biomarkers. However, their application for early disease detection remains at a standstill without suitable methods to realize their utility in the clinical setting. There thus continues to be tremendous interest in developing new technology for sensitive protein detection that is both low in cost and carries a small footprint to be able to be used at the point of care. The current gold standard method for protein biomarker detection is the ELISA, which measures protein abundance using bulky fluorescent scanners that lack portability. Here, we present a digital microfluidic platform for protein biomarker detection that is low in cost compared with standard optical detection methods, without any compromise in sensitivity. This platform furthermore makes use of simple electronics, enabling its translation into a portable handheld device, and has been developed in a manner that can easily be adapted to assay different types of proteomic biomarkers. We demonstrate its utility in quantifying not only protein abundance, but also activity. Interleukin-6 abundance could be assayed from concentrations as low as 50 pM (an order of magnitude lower than that detectable by a comparable laboratory designed ELISA) using less than 5 μL of sample, and Abelson tyrosine kinase activity was detectable in samples containing 100 pM of kinase.
Stanford Genome Technology Center, Department of Biochemistry, Stanford University, Palo Alto, CA 94304.
Janine
J
Mok
Michael N
MN
Mindrinos
Ronald W
RW
Davis
Mehdi
M
Javanmard
D015415:Biomarkers / Q000032:analysis; D017097:Electric Impedance; D015850:Interleukin-6 / Q000032:analysis*; D057230:Limit of Detection; D044085:Microfluidics / Q000379:methods*
D015415:Biomarkers; D015850:Interleukin-6
bead-based assay; biosensor; decoupled architecture